Safety and Effectiveness of a Combination Anti-HIV Drug Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 31, 1999

Study Completion Date

October 31, 2000

Conditions
HIV Infections
Interventions
DRUG

Hydroxyurea

DRUG

Abacavir sulfate

DRUG

Efavirenz

DRUG

Didanosine

Trial Locations (23)

10003

Beth Israel Med Ctr, New York

10019

Saint Luke's - Roosevelt Hosp Ctr, New York

19604

Anderson Clinical Research Inc, Reading

23666

Hampton Roads Med Specialists, Hampton

27599

Univ of North Carolina / Infectious Disease Division, Chapel Hill

28402

Univ of NC Infectious Diseases, Wilmington

29206

Burnside Clinic, Columbia

33316

Gary Richmond MD, Fort Lauderdale

33607

Saint Josephs Comprehensive Research Institute, Tampa

40536

Univ of Kentucky Med Ctr, Lexington

60657

Northstar Med Clinic, Chicago

77030

Univ of Texas / Thomas Street Clinic, Houston

77555

Univ of Texas Med Branch, Galveston

90022

Altamed Medical Health Services, Los Angeles

90211

Pacific Oaks Research, Beverly Hills

92101

St Lukes Medical Group, San Diego

94115

Pacific Horizons Med Group, San Francisco

94705

East Bay AIDS Ctr, Berkeley

331361013

Univ of Miami School of Medicine, Miami

681985400

Univ of Nebraska Medical Ctr, Omaha

021182393

Boston Med Ctr / Evans - 556, Boston

02445

CRI of New England, Brookline

02906

Miriam Hosp, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Glaxo Wellcome

INDUSTRY